Aviragen Therapeutics, Inc. 4
4 · Aviragen Therapeutics, Inc. · Filed Jul 29, 2016
Insider Transaction Report
Form 4
COLONNESE MARK P
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-07-27$1.34/sh+150,000$201,000→ 375,000 totalExercise: $1.34From: 2017-07-27Exp: 2026-07-27→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal annual installments beginning on the first anniversary and thereafter on the second and third anniversary ratably.